India-based Bharat Biotech announced on March 3, 2021, the first interim analysis of its BBV152 (COVAXIN®), the whole virion inactivated COVID-19 vaccine candidate. The first interim analysis is based on 43 cases, of which 36 cases... READ →
Coronavirus Today
/ March 4th, 2021Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.